
FDA approves extended-release formulation of ropinirole for Parkinson's disease.

NACDS supports introduction of House Bill H.R. 6252 to reform DMEPOS competitive bidding.

Ethex has voluntarily recalled additional lots of morphine tablets since they may be oversized.

OIG has released a report on FDA's generic drug review process.

Humana members in areas affected by flooding or fires can get their refills filled earlier than usual.

The Centers for Medicare & Medicaid Services will speed up its processing of low-income subsidy eligibility claims processing.

Safewy has launched a $4 generic prescription drug discount program in eastern U.S. and Chicago areas.

Medical Services Co. has agreed to sell its workers' comp business to Express Scripts.

Pharmacy directors can consult a new white paper to learn how to prepare for a Joint Commission survey on environment of care.

NCPA issued a statement regarding the Medicare Improvements for Patients and Providers Act of 2008.

An investigation by Attorney General Andrew Cuomo has found expired products at many New York drugstores.

Sen. Henry Waxman holds a hearing on what can be done to curb hospital infections

This special report takes a look at the atrial fibrillation drugs in the pipeline.

The AAN annual meeting in Chicago, researchers reported advances in treatments for a variety of neurological diseases

Patients who are taking opioids to relieve their severe pain and who are constipated can now use the new drug Relistor.

The author has mixed feelings about whether pharmacists should apologize to patients after they make a drug error.

A final rule from CMS makes no requirements for a pharmacist to be part of the dialysis team, creating concern among hospital pharmacists.

New indications, formulations, drugs, generics and over the counter products

Three new initiatives are pushing electronic medical records like never before.

FMI supermarket pharmacy conference attendees learn what new pharmacy services deparment's priorities are for 2008.

A compliance guidance for nursing homes proposed by the OIG emphasizes the need for appropriate pharmaceutical care.

The FDA recently held a hearing on behind the counter class of drugs. This article looks at the positions of various pharmacy associations and pharmacists.

The author laments about the toll standing behind the counter all day takes on his feet.

Demand for pharmacists and rising salaries is fueling increased competition among pharmacy school applicants.

FDA approves new biologic to reduce symptoms of Crohn's disease

Alcon Laboratories receives regulatory nod for new allergy spray.

The American Pharmacists Association has already put in place plans for a smooth transition to a new chief executive officer in 2009

In comments to FDA, NACDS suggests several ways in which medication guides can be improved.

GSK and Aldolor's alvimopan is approved to improve GI recovery following surgery.

The Centers for Medicare & Medicaid Services is proposing regulations to control selling tactics used by Medicare Advantage and Part D plans to attract new customers.